Biohaven Pharmaceutical Holding - Stock Price History | BHVN
Historical daily share price chart and data for Biohaven Pharmaceutical Holding since 2021 adjusted for splits. The latest closing stock price for Biohaven Pharmaceutical Holding as of September 24, 2021 is 133.38.
- The all-time high Biohaven Pharmaceutical Holding stock closing price was 138.63 on September 02, 2021.
- The Biohaven Pharmaceutical Holding 52-week high stock price is 139.66, which is 4.7% above the current share price.
- The Biohaven Pharmaceutical Holding 52-week low stock price is 61.50, which is 53.9% below the current share price.
- The average Biohaven Pharmaceutical Holding stock price for the last 52 weeks is 92.09.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Biohaven Pharmaceutical Holding Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2020 |
62.4714 |
53.3800 |
98.2400 |
27.5100 |
85.7100 |
57.44% |
| 2019 |
47.8562 |
36.6900 |
67.0100 |
34.5200 |
54.4400 |
47.21% |
| 2018 |
33.6381 |
28.0900 |
43.0000 |
22.4900 |
36.9800 |
37.06% |
| 2017 |
27.4828 |
17.5000 |
38.2100 |
17.5000 |
26.9800 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$8.865B |
$0.064B |
|
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
|
